1. Home
  2. UPC vs SCNI Comparison

UPC vs SCNI Comparison

Compare UPC & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPC
  • SCNI
  • Stock Information
  • Founded
  • UPC 1998
  • SCNI 2003
  • Country
  • UPC China
  • SCNI Israel
  • Employees
  • UPC N/A
  • SCNI N/A
  • Industry
  • UPC Biotechnology: Pharmaceutical Preparations
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • UPC Health Care
  • SCNI Health Care
  • Exchange
  • UPC Nasdaq
  • SCNI Nasdaq
  • Market Cap
  • UPC 2.0M
  • SCNI 2.3M
  • IPO Year
  • UPC 2021
  • SCNI N/A
  • Fundamental
  • Price
  • UPC $3.75
  • SCNI $2.22
  • Analyst Decision
  • UPC
  • SCNI
  • Analyst Count
  • UPC 0
  • SCNI 0
  • Target Price
  • UPC N/A
  • SCNI N/A
  • AVG Volume (30 Days)
  • UPC 25.4K
  • SCNI 95.2K
  • Earning Date
  • UPC 07-25-2025
  • SCNI 08-14-2025
  • Dividend Yield
  • UPC N/A
  • SCNI N/A
  • EPS Growth
  • UPC N/A
  • SCNI N/A
  • EPS
  • UPC N/A
  • SCNI N/A
  • Revenue
  • UPC $19,293,003.00
  • SCNI $658,000.00
  • Revenue This Year
  • UPC N/A
  • SCNI N/A
  • Revenue Next Year
  • UPC N/A
  • SCNI N/A
  • P/E Ratio
  • UPC N/A
  • SCNI N/A
  • Revenue Growth
  • UPC N/A
  • SCNI N/A
  • 52 Week Low
  • UPC $2.51
  • SCNI $1.90
  • 52 Week High
  • UPC $2,465.94
  • SCNI $8.92
  • Technical
  • Relative Strength Index (RSI)
  • UPC 45.46
  • SCNI 44.20
  • Support Level
  • UPC $3.54
  • SCNI $2.06
  • Resistance Level
  • UPC $3.96
  • SCNI $2.41
  • Average True Range (ATR)
  • UPC 0.21
  • SCNI 0.24
  • MACD
  • UPC 0.04
  • SCNI 0.01
  • Stochastic Oscillator
  • UPC 62.02
  • SCNI 20.25

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: